Dana-Farber Research: Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer (IMAGE)

Dana-Farber Cancer Institute

Dana-Farber Research: Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer

Caption

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer. The findings, from an international clinical trial led by Dana-Farber Cancer Institute researchers, reinforce earlier findings of the benefits of the drug – trastuzumab deruxtecan (T-DXd), an antibody-drug conjugate – in these patients, trial leaders say.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

Please give credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.